Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd

₹ 30.6 -2.58%
12 Apr 4:01 p.m.
About

Established in 1989, Bharat Immunological and Biologicals Corporation is a Govt. of India Undertaking biotechnology company. Company is engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets

Key Points

Product Portfolio:
a) (OPV) Polio Vaccines[1]
b) Bibcol Sanitizers[2]
c) BIB Sweet Tab[3]
d) BIBCOL BIBVIT Immunity Booster Tablet[4]
e) BIB Zinc 20mg and ORS[5][6]

  • Market Cap 132 Cr.
  • Current Price 30.6
  • High / Low 43.9 / 20.5
  • Stock P/E
  • Book Value 18.2
  • Dividend Yield 0.00 %
  • ROCE -9.27 %
  • ROE -17.7 %
  • Face Value 10.0

Pros

  • Company's working capital requirements have reduced from 34.4 days to 25.4 days

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.09% over past five years.
  • Company has a low return on equity of -22.7% over last 3 years.
  • Debtor days have increased from 39.6 to 114 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
25.36 25.20 15.62 14.22 24.70 17.43 22.04 10.48 26.48 0.00 7.65 0.00 0.00
29.86 27.47 31.54 13.18 28.19 16.41 25.71 15.31 28.98 4.72 11.67 4.31 4.68
Operating Profit -4.50 -2.27 -15.92 1.04 -3.49 1.02 -3.67 -4.83 -2.50 -4.72 -4.02 -4.31 -4.68
OPM % -17.74% -9.01% -101.92% 7.31% -14.13% 5.85% -16.65% -46.09% -9.44% -52.55%
0.14 1.20 9.08 0.25 0.22 0.12 0.59 0.14 0.32 0.10 0.49 0.10 0.16
Interest 1.17 1.30 1.22 1.16 1.23 1.54 1.68 1.58 1.74 1.67 2.06 1.72 2.09
Depreciation 0.06 0.06 0.06 0.06 0.06 0.04 0.05 0.04 0.04 0.04 0.09 0.03 0.03
Profit before tax -5.59 -2.43 -8.12 0.07 -4.56 -0.44 -4.81 -6.31 -3.96 -6.33 -5.68 -5.96 -6.64
Tax % 30.77% 21.81% 19.46% -2,642.86% -105.26% 25.00% 11.02% 20.76% 22.22% 26.07% 31.69% 23.15% 26.05%
-3.87 -1.89 -6.53 1.93 -9.36 -0.33 -4.28 -5.00 -3.08 -4.68 -3.88 -4.59 -4.92
EPS in Rs -0.90 -0.44 -1.51 0.45 -2.17 -0.08 -0.99 -1.16 -0.71 -1.08 -0.90 -1.06 -1.14
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
46 173 203 146 128 124 35 84 67 85 78 45 8
41 164 191 143 132 111 43 93 77 106 83 63 25
Operating Profit 6 9 12 3 -4 13 -8 -9 -10 -21 -5 -18 -18
OPM % 12% 5% 6% 2% -3% 10% -23% -11% -16% -24% -6% -41% -232%
2 1 6 1 1 1 1 4 1 2 1 3 1
Interest 0 2 6 1 6 4 1 2 5 5 6 7 8
Depreciation 1 1 1 1 1 1 0 0 0 0 0 0 0
Profit before tax 6 7 11 2 -9 9 -8 -7 -14 -24 -10 -23 -25
Tax % -111% 27% 42% 26% 31% 29% 46% 21% 28% 25% 10% 25%
13 5 6 2 -6 7 -4 -6 -10 -18 -9 -17 -18
EPS in Rs 2.91 1.16 1.48 0.36 -1.44 1.51 -0.99 -1.34 -2.36 -4.19 -2.03 -3.95 -4.18
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -13%
5 Years: 5%
3 Years: -13%
TTM: -90%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -31%
TTM: -42%
Stock Price CAGR
10 Years: 12%
5 Years: 28%
3 Years: -7%
1 Year: 20%
Return on Equity
10 Years: -12%
5 Years: -24%
3 Years: -23%
Last Year: -18%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 43 43 43 43 43 43 43 43 43 43 43 43 43
Reserves -15 -1 -3 -2 -8 -1 -6 -12 -23 -9 62 45 36
7 0 -1 -9 9 0 0 32 3 27 78 70 74
45 48 52 48 24 17 16 62 103 43 29 28 35
Total Liabilities 81 90 91 80 68 59 53 125 127 104 213 186 188
9 8 7 6 6 5 5 5 4 4 116 115 115
CWIP 1 0 0 0 0 0 0 0 0 32 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
71 82 84 74 63 53 48 120 122 68 97 70 73
Total Assets 81 90 91 80 68 59 53 125 127 104 213 186 188

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
5 31 -12 8 -9 -17 3 -32 34 12 -42 11
-0 0 0 0 1 0 -1 1 1 1 1 0
-3 -0 -6 -1 -2 -3 -1 31 -34 -12 45 -15
Net Cash Flow 2 31 -18 7 -10 -20 1 -1 1 0 3 -3

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 209 2 47 34 37 19 167 318 96 0 5 114
Inventory Days 241 87 66 84 77 2 23 67 308 56 202 13
Days Payable 316 99 70 103 26 1 6 204 259 61 5 4
Cash Conversion Cycle 134 -9 43 16 88 19 185 181 145 -5 203 122
Working Capital Days 34 -20 19 -2 55 -19 59 151 -91 -57 135 25
ROCE % 20% 23% 42% 9% -8% 31% -18% -11% -22% -46% -3% -9%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25%
40.75% 40.75% 40.75% 40.75% 40.75% 40.75% 40.75% 40.75% 40.74% 40.74% 40.75% 40.75%
No. of Shareholders 33,93838,19536,79936,86936,32335,69535,44236,24235,55034,81834,20134,910

Documents